Welcome to...The UCLA Endocrine Surgical Unit
 

Schedule an Appointment
Endocrine Home
About Us
Our Expert Team
Our Services
First Visit for Patients
Patient Education
  Getting started
  Benefits of parathyroid surgery
  About endocrine surgery
  History of endocrine surgery
  Outcomes in endocrine surgery
  Health Care Quality and Safety
  Reputable web resources
  Diseases we treat
  Endocrine encyclopedia
  Adrenocortical Carcinoma
Scar Gallery
For Referring Physicians
Distance Surgery Program
International Patients
Insurance Questions
Map-Directions-Parking
Contact Us
Patient Experiences
Site Map

UCLA Health System


Schedule an Appointment


Patient Education - Endocrine Encyclopedia

Endocrine Surgery Encyclopedia

Multiple endocrine neoplasia (MEN) type 2

Definition:
Multiple Endocrine Neoplasia II (MEN II) is a hereditary disorder in which a type of thyroid cancer accompanied by recurring cancer of the adrenal glands.

One type of this disease (MEN IIa) is also associated with overgrowth (hyperplasia) of the parathyroid gland.

Alternative Names: Sipple's syndrome

Causes, incidence, and risk factors:
The cause of MEN II is genetic -- a mutation in a gene called RET. Multiple tumors may appear in the same person, but not necessarily at the same time. The adrenal tumor is a pheochromocytoma and the thyroid tumor is a medullary carcinoma of the thyroid.

The disorder may occur at any age, and affects men and women equally. The main risk factor is a family history of MEN II.

Symptoms:

  • Severe headache
  • Heart palpitations
  • Rapid heart rate
  • Sweating
  • Chest pain
  • Abdominal pain
  • Nervousness
  • Irritability
  • Loss of weight
  • Diarrhea
  • Cough
  • Cough with blood
  • Fatigue
  • Back pain
  • Increased urine output
  • Increased thirst
  • Loss of appetite
  • Nausea
  • Muscular weakness
  • Depression
  • personality changes

The symptoms may vary, but are consistent with those of pheochromocytoma, medullary carcinoma of the thyroid, and sometimes hyperparathyroidism.

Signs and tests:

Diagnosis depends on identification of mutation of the RET gene. This can be done with a blood test.

A physical examination may reveal enlarged cervical lymph nodes. An examination of the thyroid may reveal a single or multiple thyroid nodules. The patient may have high blood pressure (sustained or episodic), rapid heart rate and fever.

In MEN IIb, mucosal neuromas (benign tumors of the mucosa) may be present, as well as puffy lips and a prominent jaw.

Diagnostic tests are also used to evaluate the function of each endocrine gland. These tests help confirm the diagnosis:

  • Adrenal biopsy showing pheochromocytoma
  • MIBG scintiscan showing tumor
  • MRI of abdomen showing adrenal mass
  • Abdominal CT scan showing mass
  • Elevated urine metanephrine
  • Elevated urine catecholamines
  • Thyroid biopsy showing medullary carcinoma cells
  • Ultrasound of the thyroid revealing nodule
  • Thyroid scan showing cold nodule
  • Elevated calcitonin
  • Parathyroid biopsy showing tumor or hyperplasia
  • Radioimmune assay of parathyroid hormone showing increased level
  • Increased serum calcium
  • Decreased serum phosphorus
  • Possibly increased serum alkaline phosphatase
  • Imaging of the kidneys or ureters showing calcification or obstruction
  • ECG possibly showing abnormalities

Treatment:
Surgery is needed to remove both the medullary carcinoma of the thyroid and the pheochromocytoma. Medullary carcinoma of the thyroid must be treated with total removal of the thyroid gland and removal of surrounding lymph nodes. Hormone replacement therapy is given after surgery.

Family members should be screened for the RET gene mutation.

Support Groups:

Expectations (prognosis):
Pheochromocytoma is usually benign (not cancer), but the accompanying medullary carcinoma of the thyroid that characterizes this condition is a very aggressive and potentially fatal cancer. Nonetheless, early diagnosis and surgery can often lead to cure.

Complications:
A complication is the metastasis of cancerous cells.

Calling your health care provider:
Call your health care provide if you notice symptoms of MEN II.

Prevention:
Screening of close relatives of a person with MEN II may lead to early detection.



Review Date: 11/9/2004
Reviewed By: Marcia S. Brose, M.D., Ph.D., Assistant Professor, Hematology/Oncology, The University of Pennsylvania Cancer Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.

A.D.A.M. qualityA.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. logo


Diseases of the Endocrine System

Tests and studies: